ly 171883 has been researched along with Chronic Illness in 1 studies
LY 171883: structure in first source; leukotriene receptor antagonist
tomelukast : A member of the class of acetophenones that is 1-phenylethanone substituted at position 2 by a hydroxy group, a propyl group at position 3 and a 4-(1H-tetrazol-5-yl)butoxy group at position 4. A leukotriene antagonist, it exhibits anti-asthmatic activity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cloud, ML | 1 |
| Enas, GC | 1 |
| Kemp, J | 1 |
| Platts-Mills, T | 1 |
| Altman, LC | 1 |
| Townley, R | 1 |
| Tinkelman, D | 1 |
| King, T | 1 |
| Middleton, E | 1 |
| Sheffer, AL | 1 |
1 trial available for ly 171883 and Chronic Illness
| Article | Year |
|---|---|
A specific LTD4/LTE4-receptor antagonist improves pulmonary function in patients with mild, chronic asthma.
Topics: Acetophenones; Adolescent; Adult; Asthma; Chemical Phenomena; Chemistry; Chronic Disease; Female; Fo | 1989 |